​

Funding Round

Post-IPO Equity - Amyris

Post-IPO Equity - Amyris

Investment Firm

Overview

Amyris Biotechnologies specializes in creating renewable products focusing on fuels and chemicals.

Announced Date

Aug 03, 2017

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

Vivo Capital

Vivo Capital

Vivo Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

DSM

DSM

No designation

Participant Investors

2

Investor Name
Participant InvestorDSM
Participant InvestorVivo Capital

Round Details and Background

Amyris raised $50000000 on 2017-08-03 in Post-IPO Equity

Amyris Biotechnologies specializes in creating renewable products focusing on fuels and chemicals.

Company Funding History

26

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 14, 2008
Series B - Amyris
4-21.0M
Oct 12, 2006
Series A - Amyris
3-20.0M
Sep 19, 2007
Series B - Amyris
4-70.0M
Oct 01, 2009
Series C - Amyris
4-41.8M

Recent Activity

There is no recent news or activity for this profile.